Taheri S - Search Results

1

Cyclosporine in the treatment of membranoproliferative glomerulonephritis.

Bagheri N, Nemati E, Rahbar K, Nobakht A, Einollahi B, Taheri S. Bagheri N, et al. Among authors: taheri s. Arch Iran Med. 2008 Jan;11(1):26-9. Arch Iran Med. 2008. PMID: 18154419

2

Renal allograft in a professional boxer.

Einollahi B, Nafar M, Taheri S, Nemati E. Einollahi B, et al. Among authors: taheri s. Saudi J Kidney Dis Transpl. 2008 Mar;19(2):241-3. Saudi J Kidney Dis Transpl. 2008. PMID: 18310875

3

Human leukocyte antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: an attempt toward individualization of immunosuppression.

Nemati E, Taheri S, Pourfarziani V, Einollahi B. Nemati E, et al. Among authors: taheri s. Ann Transplant. 2008;13(2):32-6. Ann Transplant. 2008. PMID: 18566557 Free article.

4

Cytomegalovirus disease in renal transplant recipients: an Iranian experience.

Nemati E, Taheri S, Pourfarziani V, Einollahi B. Nemati E, et al. Among authors: taheri s. Exp Clin Transplant. 2008 Jun;6(2):132-6. Exp Clin Transplant. 2008. PMID: 18816240 Free article.

5

Approach to a target value for 2-hours post dose cyclosporine (C2) during the first week post renal transplantation.

Einollahi B, Taheri S, Lessan-Pezeshki M, Pourfarziani V, Hosseini MS, Nemati E, Ghadiani MH, Abbaszadeh S, Nourbala MH. Einollahi B, et al. Among authors: taheri s. Ann Transplant. 2009 Jan-Mar;14(1):18-22. Ann Transplant. 2009. PMID: 19289992

6

Vaginal tuberculosis in an elderly kidney transplant recipient.

Nemati E, Taheri S, Nourbala MH, Einollahi B. Nemati E, et al. Among authors: taheri s. Saudi J Kidney Dis Transpl. 2009 May;20(3):465-7. Saudi J Kidney Dis Transpl. 2009. PMID: 19414953

7

Cyclosporine trough (C0) and 2-hour postdose (C2) levels: which one is a predictor of graft loss?

Nemati E, Einollahi B, Taheri S, Moghani-Lankarani M, Kalantar E, Simforoosh N, Nafar M, Saadat AR. Nemati E, et al. Among authors: taheri s. Transplant Proc. 2007 May;39(4):1223-4. doi: 10.1016/j.transproceed.2007.02.005. Transplant Proc. 2007. PMID: 17524938 Clinical Trial.

8

Laboratory variables and treatment adequacy in hemodialysis patients in Iran.

Pourfarziani V, Ghanbarpour F, Nemati E, Taheri S, Einollahi B. Pourfarziani V, et al. Among authors: taheri s. Saudi J Kidney Dis Transpl. 2008 Sep;19(5):842-6. Saudi J Kidney Dis Transpl. 2008. PMID: 18711312

9

Prevalence of hypertension among Iranian hemodialysis patients and associated risk factors: a nationwide multicenter study.

Nemati E, Ghanbarpour F, Taheri S, Einollahi B. Nemati E, et al. Among authors: taheri s. Pak J Biol Sci. 2008 Mar 15;11(6):910-4. doi: 10.3923/pjbs.2008.910.914. Pak J Biol Sci. 2008. PMID: 18814655

10

Electrocardiographic manifestations of hyperkalemia in hemodialysis patients.

Nemati E, Taheri S. Nemati E, et al. Among authors: taheri s. Saudi J Kidney Dis Transpl. 2010 May;21(3):471-7. Saudi J Kidney Dis Transpl. 2010. PMID: 20427871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

814 results

Search Page

Filters